Adverse Events Associated with Immune Checkpoint Blockade

Overview of attention for article published in New England Journal of Medicine, March 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

blogs: 2 blogs
twitter: 42 X users
patent: 4 patents

facebook: 1 Facebook page
guideline: 2 clinical guideline sources
bluesky: 2 Bluesky users

So far, Altmetric has seen 58 X posts from 42 X users, with an upper bound of 192,941 followers.

@MaxKonigMD @LCalabreseDO @EJohnWherry @DamanLangguth @CCalabreseDO @alhkim @RheumNow @HealioRheum @LillyPad Big fan of abatacept for this, but I confess I am a little biased https://t.co/4bw10cSWtH

RT @kdjhaveri: Immunotherapy associated renal disease #NKFClinicals https://t.co/OxKkdXyPAZ https://t.co/W65hndwFLX

@nephondemand @always_oncall @VelezNephHepato That figure is outdated. Since we had that review in @AmJNephrol , several glomerular diseases have been reported even with pd1 inhibitors. https://t.co/3MOPgJRbQE @onconeph @renalmyeloma @SWadhwaniMD

RT @kdjhaveri: Immunotherapy associated renal disease #NKFClinicals https://t.co/OxKkdXyPAZ https://t.co/W65hndwFLX

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 54 additional X posts.